Michael Breininger

Corporate Controller at Ocugen

No bio yet


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Ocugen

1 followers

Ocugen Inc. (NASDAQ: OCGN) is a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19.


Industries

Employees

51-200

Links